Suchergebnisse - "Lung"

PubPharm (131.693)

1

Esophageal Motility Abnormalities in Lung Transplant Recipients With Esophageal Acid Reflux Are Different From Matched Controls

enthalten in: Journal of neurogastroenterology and motility | 2024

von Elsheikh, M. | Akanbi, L. | Selby, L. | +1

2

Proteomic analysis of multiple organ dysfunction induced by rhabdomyolysis

enthalten in: Journal of proteomics | 2024

von Zhang, Y. | Lyu, Q. | Han, X. | +5

3

Prevalence of Chronic Pulmonary Aspergillosis in Two (2) Tuberculosis Treatment Clinics in Lagos, Nigeria : A Prospective Longitudinal Study

enthalten in: Open forum infectious diseases | 2024

von Davies, A. | Adekoya, A. | Balogun, O. | +6

4

Baicalin reduces inflammation to inhibit lung cancer via targeting SOCS1/NF-κB/STAT3 axis

enthalten in: Heliyon | 2024

von Guo, L. | Yue, M. | Ma, C. | +3

5

Identification of CNKSR1 as a biomarker for "cold" tumor microenvironment in lung adenocarcinoma : An integrative analysis based on a novel workflow

enthalten in: Heliyon | 2024

von Cai, Q. | Peng, M.

6

Human mesenchymal stem cells increase LLC metastasis and stimulate or decelerate tumor development depending on injection method and cell amount

enthalten in: Cytometry. Part A : the journal of the International Society for Analytical Cytology | 2024

von Stepanov, Y. | Golovynska, I. | Ostrovska, G. | +10

7

Tumor markers for lipid metabolism-related genes : Based on small cell lung cancer and bronchial asthma dual analysis

enthalten in: Environmental toxicology | 2024

von Wang, X. | Gao, Y. | Wang, H. | +2

8

Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC) : Study protocol

enthalten in: Thoracic cancer | 2024

von Deng, L. | Shayan, G. | Jiang, W. | +2

9

Impact of biologics on lung hyperinflation in patients with severe asthma

enthalten in: Respiratory medicine | 2024

von Maniscalco, M. | Candia, C. | Calabrese, C. | +4

10

Risk of interstitial lung disease with the use of programmed cell death 1 (PD-1) inhibitor compared with programmed cell death ligand 1 (PD-L1) inhibitor in patients with breast cancer : A systematic review and meta-analysis

enthalten in: Cancer pathogenesis and therapy | 2024

von Guo, L. | Lin, X. | Lin, X. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13170]